Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06283030 · ClinicalTrials.gov registry record · NA
Evaluation of Hypoglossal Nerve Stimulation in Humans With Obstructive Sleep Apnea
A NA study of Sleep Apnea, Obstructive and Sleep Apnea, sponsored by Invicta Medical.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT06283030: Completed NA study of Sleep Apnea, Obstructive and Sleep Apnea, sponsored by Invicta Medical.
NCT06283030 is a NA study of Sleep Apnea, Obstructive and Sleep Apnea that has completed, run by Invicta Medical. The registered enrollment target is 14 participants, below the 262-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06283030, a NA study of Sleep Apnea, Obstructive and Sleep Apnea, has completed, sponsored by Invicta Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
This proof-of-concept study is being performed to evaluate whether the hypoglossal nerve can be stimulated using a small series of electrodes placed surgically via a percutaneous approach. Minimally invasive off the shelf medical devices will be used and observation of the characteristic physiological responses to stimulation of the HGN, will be assessed.
Primary Outcome
Consistent identification of and access to the target stimulation location aligned with the medial branch of the Hypoglossal Nerve.
Conditions Studied
Interventions
- DEVICE Hypoglossal nerve stimulation
Study Locations (1)
Tennessee
- Vanderbilt Bill Wilkerson Centre - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2021-12-01 |
| Est. Completion | 2023-09-25 |
| Phase | NA |
What the finished NCT06283030 record still lists
NCT06283030 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 262-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (95% lower).
The record links to 4 conditions, with Sleep Apnea, Obstructive appearing as the primary indexed condition, and to 1 intervention - of which Hypoglossal nerve stimulation is the first listed.
NCT06283030 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT06283030 about?
NCT06283030 is a clinical study titled "Evaluation of Hypoglossal Nerve Stimulation in Humans With Obstructive Sleep Apnea". This proof-of-concept study is being performed to evaluate whether the hypoglossal nerve can be stimulated using a small series of electrodes placed surgically via a percutaneous approach. Minimally invasive off the shelf medical devices will be used and observation of the characteristic physiologic...
What is the current status of trial NCT06283030?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2021-12-01. Estimated completion is 2023-09-25.
What conditions does trial NCT06283030 study?
This clinical trial studies the following conditions: Sleep Apnea, Obstructive, Sleep Apnea, Sleep Disorder, Sleep Apnea Syndromes.
What interventions are being tested in trial NCT06283030?
The interventions under investigation include: Hypoglossal nerve stimulation (DEVICE).
Who is sponsoring clinical trial NCT06283030?
This trial is sponsored by Invicta Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06283030 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Apnea, Obstructive
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06283030's enrollment target sits among peer trials
14 44th of 45 higher than 2 of 45 other Sleep Apnea, Obstructive trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep Apnea, Obstructive trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The PREDICTOR Study: Assessing Diagnostic Predictors of Airway Collapse in Patients With Obstructive Sleep Apnea
RECRUITING · NA
-
Home Apnea Testing in CHildren Trial
RECRUITING · NA
-
Lateral Pharyngoplasty Outcomes in Children Undergoing Tonsillectomy
RECRUITING · NA
-
The REPOSE (Reach for Equity in Pediatric Sleep Evaluation) Navigation Intervention
RECRUITING · NA
-
Type 1 Diabetes and Obstructive Sleep Apnea
RECRUITING · NA
-
NPA-OSA Device Tolerability, Usability and Acclimation Clinical Study in Adult Obstructive Sleep Apnea (OSA) Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy